Showing results (21-30 of 444) with videos related to

Sort By:
Pageof 45
Expert Opinion on Drug Metabolism & Toxicology|February 1, 2017
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug developmentAnna Girardi, Emanuel Raschi, Silvia Galletti, et al.
Journal of Nephrology|November 11, 2021
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systemsMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
Expert Opinion on Drug Safety|July 19, 2021
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting systemMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic AppraisalEmanuel Raschi, Michele Fusaroli, Milo Gatti, et al.
British Journal of Clinical Pharmacology|July 9, 2020
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19Milo Gatti, Michele Fusaroli, Paolo Caraceni, et al.
Current Medicinal Chemistry|October 30, 2013
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspectiveElisabetta Poluzzi, Carlo Piccinni, Emanuel Raschi, et al.
British Journal of Clinical Pharmacology|March 23, 2024
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forwardElisabetta Poluzzi, Emanuel Raschi, Carlotta Lunghi, et al.
BMC Complementary and Alternative Medicine|July 25, 2014
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based surveyAnna Girardi, Carlo Piccinni, Emanuel Raschi, et al.
Pageof 45